Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70377-078

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70377-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure of atorvastatin calcium, showing the molecular arrangement including hydroxyl groups, fluorophenyl group, and calcium ion complexation with waters of hydration.*

FDA Label Image

Figure 1 (Figure 1)

A line graph displaying cumulative incidence (%) over time (years) comparing Atorvastatin and placebo groups. The Atorvastatin line shows a lower cumulative incidence rate compared to placebo over a period up to 3.5 years. The graph includes hazard ratio (HR=0.64) with confidence interval (0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Figure 2 (Figure 2)

A line graph comparing cumulative hazard percentages over time between atorvastatin and placebo groups. The x-axis measures time in years up to 5 years, while the y-axis displays cumulative hazard percentage. The atorvastatin group shows consistently lower cumulative hazard than placebo, with a hazard ratio of 0.63 (95% CI 0.48-0.83) and p value 0.001.*

FDA Label Image

Figure 3 (Figure 3)

A line graph comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. Two curves indicate event rates for 10 mg (dashed line) and 80 mg (solid line) dosage groups, with a hazard ratio (HR) of 0.78 and p-value of 0.0002 noted on the graph.*

FDA Label Image

Container Label-10mg.jpg (Container Label 10mg)

Atorvastatin Calcium 10 mg film-coated tablets carton label from Biocon Pharma Inc., containing 90 tablets. The label includes dosage strength, NDC 70377-077-11, child-resistant packaging warning, storage instructions at 20°C to 25°C, and manufacturing details from Biocon Pharma Inc. in the USA and Recipharm Pharmaservices Pvt Ltd., Bengaluru, India.*

FDA Label Image

Container Label-20mg.jpg (Container Label 20mg)

The packaging label for Atorvastatin Calcium Tablets, USP, features 20 mg strength film-coated tablets. The label displays the NDC number 70377-078-11, indicates Rx Only status, and specifies a bottle containing 90 tablets. The labeler is Biocon Pharma Inc., with manufacturing details and storage instructions included. The design incorporates blue, white, and red color elements with text about dosage use and safety.*

FDA Label Image

Container Label-40mg.jpg (Container Label 40mg)

Label for Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets by Biocon Pharma Inc. The label includes NDC 70377-079-11, dosing information advising to see the package insert, storage instructions at 20°C to 25°C (68°F to 77°F), and warnings about child resistance and keeping out of reach of children. It states the package contains 90 tablets and includes manufacturing details for Biocon Pharma Inc. and Reipharm Pharmaservices Pvt. Ltd.*

FDA Label Image

Container Label-80mg.jpg (Container Label 80mg)

Label for Atorvastatin Calcium Tablets, USP 80 mg film-coated tablets. The label includes the NDC 70377-080-11 and indicates a package size of 90 tablets. It is manufactured by Biocon Pharma Inc. with additional manufacturing by Recipharm Pharmaservices Pvt. Ltd., Bengaluru, India. Storage instructions and dosage use notes are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.